Hurdles of CAR-T Cell-Based Cancer Immunotherapy Directed Against Solid Tumors

Science China Life Sciences - China
doi 10.1007/s11427-016-5027-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

CAR T-Cell Therapy for Solid Tumors?

Cancer Discovery
Oncology
2018English

Targeting High-Risk Pediatric Solid Tumors With CAR T Cells Directed Against ALK (Anaplastic Lymphoma Kinase, CD246)

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

Toxicities of CD19 CAR-T Cell Immunotherapy

American Journal of Hematology
Hematology
2019English

Editorial: Dendritic Cell-Based Immunotherapy in Solid and Haematologic Tumors

Frontiers in Immunology
AllergyImmunology
2020English

Making CAR T Cells a Solid Option for Solid Tumors

Frontiers in Immunology
AllergyImmunology
2018English

Advances in Cancer Immunotherapy in Solid Tumors

Cancers
Cancer ResearchOncology
2016English

IL15 and T-Cell Stemness in T-Cell-Based Cancer Immunotherapy

Cancer Research
Cancer ResearchOncology
2015English

Armed T Cells With CAR for Cancer Immunotherapy

Science China Life Sciences
GeneticsMolecular BiologyEnvironmental ScienceBiochemistryBiological SciencesAgricultural
2016English

Targeting T Cell Malignancies Using CAR-based Immunotherapy: Challenges and Potential Solutions

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy